DCF Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,000
Closed -$438K 104
2024
Q2
$438K Buy
3,000
+1,500
+100% +$223K 0.23% 72
2024
Q1
$237K Hold
1,500
0.12% 73
2023
Q4
$235K Hold
1,500
0.13% 70
2023
Q3
$234K Sell
1,500
-4,613
-75% -$761K 0.13% 81
2023
Q2
$1.01M Buy
+6,113
New +$987K 0.53% 39
2021
Q3
Sell
-5,000
Closed -$824K 89
2021
Q2
$824K Hold
5,000
0.29% 52
2021
Q1
$822K Hold
5,000
0.36% 56
2020
Q4
$787K Buy
+5,000
New +$738K 0.32% 56

Other funds holding JNJ

DCF Advisers's JNJ Position: Q3 2024 in Review

DCF Advisers sold out of Johnson & Johnson (JNJ) in Q3 2024, closing a stake of 3,000 shares — an estimated $438K sold.

DCF Advisers first reported a position in JNJ in Q4 2020 and held it in 8 quarters. The position peaked at $1.01M in Q2 2023. 3,882 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • DCF Advisers reported no remaining Johnson & Johnson position as of Q3 2024 after selling out during the quarter.
  • DCF Advisers sold 3,000 Johnson & Johnson shares in Q3 2024, an estimated $438K.
  • DCF Advisers first reported a position in Johnson & Johnson in Q4 2020 and held it in 8 quarters.
  • DCF Advisers's Johnson & Johnson position peaked at $1.01M in Q2 2023.
  • 3,882 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on DCF Advisers's 13F filing for Q3 2024, filed 13 Nov 2024.